You are here

Bioiberica guarantees that its sodium heparin will comply with the new parameters of the European Pharmacopeia

10 Jun 2013

Bioiberica participated in two studies to establish the standard ranges of activity of Anti-factor Xa and anti-IIa of sodium heparin organized by EDQM, which will be included in the new revision of the monograph of the European Pharmacopoeia.

The results obtained with our product perfectly fit within the new established range. Therefore, we can guarantee that our sodium heparin will comply without any problem with the new parameters of the Pharmacopoeia.

Additionally Bioiberica wishes to inform its customers that the most relevant tests required for certification of the new EP have been performed with its sodium heparin  and we can announce that we are prepared for the upcoming changes.